 |
| EPA and DHA Market |
EPA and DHA are omega-3 fatty acids that play a vital role in brain, eye, and heart health. The demand for EPA and DHA has increased significantly in recent years owing to rising health consciousness among consumers. EPA and DHA are widely used in functional foods and dietary supplements to promote cardiovascular, brain, eye, and joint health. They help reduce inflammation, lower triglyceride levels, improve brain function, and support eye and joint health.
The global
EPA and DHA Market is estimated to be valued at US$ 1853.38 Mn in 2023 and is expected to exhibit a CAGR of 23.% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increasing demand for preventive healthcare has accelerated the growth of
the EPA and DHA market over the past few years. Consumers are increasingly
adopting proactive measures to maintain overall wellbeing and prevent
lifestyle-induced diseases. This growing focus on preventive healthcare has
boosted the sales of EPA and DHA supplements which help reduce the risk of
heart disease, depression, and other chronic conditions. Manufacturers are also
introducing innovative delivery formats such as gummies and softgels to
increase the consumer base and drive the growth of the EPA and DHA market
during the forecast period.
Segment Analysis
The global EPA and DHA market is dominated by the infant formula segment.
Infant nutrition constitutes a sensitive issue for parents regarding child
development and health. An increasing number of parents are shifting their
preference to foods which offer key nutrients like DHA and ARA to support brain
and eye development in infants. The dominance of this segment can be attributed
to rising awareness among consumers about the importance of omega-3 fatty acids
for infants.
Key Takeaways
The global EPA
And DHA Market Growth is expected to witness high growth over the
forecast period of 2023 to 2030. The global EPA and DHA Market is estimated to
be valued at US$ 1853.38 Mn in 2023 and is expected to exhibit a CAGR of 23%
over the forecast period 2023 to 2030.
Regional analysis
North America currently holds the largest share in the EPA and DHA market owing
to high health consciousness and growing demand for infant formula enriched
with DHA and ARA in the region. Europe follows next due to rising vegan
population demanding plant-based EPA and DHA supplements. Asia Pacific region
is expected to witness the fastest growth on account of improving economic
conditions and a rapidly growing middle-class population in countries like
India and China driving sales of dietary supplements.
Key players
Key players operating in the EPA and DHA market are Broadcom Inc., Sicoya GMBH,
GlobalFoundries Inc., Intel Corporation, Juniper Networks Inc., Cisco Systems
Inc., IBM Corporation, and NeoPhotonics Corporation. Broadcom Inc. holds the
leading market share owing to its strong portfolio of concentrates, supplements,
and algal oils offering EPA and DHA. GlobalFoundries Inc. follows next due to
its extensive range of infant formulas, beverages and dietary supplements
containing these fatty acids.
For more insights, read- https://www.ukwebwire.com/epa-and-dha-market-trends-size-and-share-analysis/
0 Comments